Home Life Sciences Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes
Article
Licensed
Unlicensed Requires Authentication

Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes

  • Bettina Grismayer , Sumito Sato , Charlotte Kopitz , Christian Ries , Susanne Soelch , Manfred Schmitt , Gustavo Baretton , Achim Krüger , Thomas Luther , Matthias Kotzsch and Viktor Magdolen EMAIL logo
Published/Copyright: November 13, 2012

Abstract

mRNA levels of the urokinase receptor splice variant uPAR-del4/5 are associated with prognosis in breast cancer. Its overexpression in cancer cells affects tumor biologically relevant processes. In the present study, individual breast cancer cell clones displaying low vs. high uPAR-del4/5 expression were analyzed demonstrating that uPAR-del4/5 leads to reduced cell adhesion and invasion in a dose-dependent manner. Additionally, matrix metalloproteinase-9 (MMP-9) was found to be strongly upregulated in uPAR-del4/5 overexpressing compared to vector control cells. uPAR-del4/5 may thus play an important role in the regulation of the extracellular proteolytic network and, by this, influence the metastatic potential of breast cancer cells.


Corresponding author: Viktor Magdolen, Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany

Received: 2012-5-16
Accepted: 2012-7-2
Published Online: 2012-11-13
Published in Print: 2012-12-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Guest Editorial
  4. Highlight: 29th Winter School on Proteinases and Their Inhibitors
  5. Highlight: 29th Winter School on Proteinases and their Inhibitors
  6. Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases
  7. Effects of cathepsin K deficiency on intercellular junction proteins, luminal mucus layers, and extracellular matrix constituents in the mouse colon
  8. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins
  9. Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines
  10. Dissecting the impact of Frizzled receptors in Wnt/β-catenin signaling of human mesenchymal stem cells
  11. Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes
  12. IGF-I receptor phosphorylation is impaired in cathepsin X-deficient prostate cancer cells
  13. Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF-β1 activation and reduces regulatory ID gene expression
  14. Gingipain aminopeptidase activities in Porphyromonas gingivalis
  15. CLIPPER: an add-on to the Trans-Proteomic Pipeline for the automated analysis of TAILS N-terminomics data
  16. Review
  17. Integration of cellular bioenergetics with mitochondrial quality control and autophagy
  18. Research Articles/Short Communications
  19. Genes and Nucleic Acids
  20. A conformational switch is responsible for the reversal of the 6S RNA-dependent RNA polymerase inhibition in Escherichia coli
  21. Protein Structure and Function
  22. Molecular determinants of human dipeptidyl peptidase III sensitivity to thiol modifying reagents
  23. Modular structure of HEL protein from Arabidopsis reveals new potential functions for PR-4 proteins
  24. Proteolysis
  25. Characterization of angiotensin I-converting enzyme N-domain selectivity using positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides
  26. Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis
Downloaded on 14.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2012-0206/html
Scroll to top button